Benjamin Rich

Assistant Professor of Radiation Oncology @SylvesterCancer @UmiamiHealth

[Benjamin Rich @BenRichMD]

@TylerSbrt @cpeedell @jryckman3 @urotoday @zklaassen_md @DanaFarber @TDorffOnc @cityofhope The rare patient with a contraindication to RT may benefit from peri-op ADT+ARPI. Beyond this small subset of patients it is hard to see the utility here.

[Benjamin Rich @BenRichMD]

@DrSpratticus @WallisCJD @ChrisSweens1 Publication out in NEJM https://t.co/1fPSEgEiiD

[Benjamin Rich @BenRichMD]

Beautiful day to ride across South Florida to @TackleCancer at @SylvesterCancer #DCCXVI

[Benjamin Rich @BenRichMD]

@NeuroOnc @ASTRO_org

[Benjamin Rich @BenRichMD]

🧠 Brain Tumor physicians (Neuro Onc, Med Onc, Rad Onc, Nsgy):

Help us assess IDHm glioma practice patterns by completing a 5–7 min anonymous survey. Enter to win one of two $50 Amazon gift cards.

👉 [Survey link] https://t.co/wYgja16EnK

[Daniel E Spratt @DrSpratticus]

X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere.

The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI @US_FDA and dedicated my career to help men and their families suffering from PCa

@nytimes @WSJ @FoxNews @CNN @NBCNews @Reuters @ASCO @PCFnews @DeptofDefense

[Dr. Andrew Loblaw @DrAndrewLoblaw]

@AlbertoBossial #PEACE 1 RT arm just dropped in @TheLancet

Systemic Rx (61% doce 50% abi) + RT ↑ time to CRPC +GU toxicity for BOTH low and high-volume pts +↑ PFS for those on abi. RT for all!

Article: https://t.co/gpHvWnrbpu
@cristian_udo Editorial: https://t.co/f157EGmdiJ

[Benjamin Rich @BenRichMD]

Univ of Miami Rad Onc 🔥

[Dr. Brandon Mahal @BrandonMahal]

Excited by this year’s highly competitive group! In-person interviews will be January 21, 23, and 30, with flights and hotels covered. We have many exciting updates as we’ve positioned our program at the forefront of modern training and learning! 🚀 📈@ARRO_org @ASTRO_org

[Benjamin Rich @BenRichMD]

Well-done paper on recurrence detection for HPV+ oropharyngeal cancer. Will be interesting to see how detection method changes with more routine ctDNA surveillance testing.

[JAMA Otolaryngology – Head & Neck Surgery @JAMAOto]

Across an 8-year span, 80% of patients with recurrent HPV+ oropharyngeal cancer had their recurrence detected through symptom changes vs imaging surveillance. https://t.co/U7FJL8f1n1

[Lea Alhilali, MD @teachplaygrub]

1/They say form follows function!

Brain MRI anatomy is best understood in terms of both form & function.

Here’s a short thread to help you to remember important functional brain anatomy--so you truly can clinically correlate!

[Crystal Seldon Taswell, MD @CrystalSeldon]

Congratulations @laurafreedman1 and @ctakita1 #UMiami #FASTRO

[Benjamin Rich @BenRichMD]

No survival benefit with TMZ in elderly patients (majority over age 70) with "truly" unmethylated MGMTp glioblastoma, and RT alone superior to TMZ alone. ~45% GBMs meet cutoff of "truly" unmethylated.
Nice analysis of NOA-08 and CE.6 in Neuro-Onc. https://t.co/PytRqoVqLd

[Benjamin Rich @BenRichMD]

Nice review on the work-up and management of leptomeningeal disease, an entity that unfortunately we see commonly in our practice.

https://t.co/fnZeO6Qt8n

[Benjamin Rich @BenRichMD]

@SamuelKareffMD @JAMANetworkOpen @OncLive @GlopesMd @Jani_Chinmay @ManuelDomine @ngelRodrguezPr5 Interesting work

[Benjamin Rich @BenRichMD]

@5_utr @NiuSanford Agreed. Something like half of drugs don’t show efficacy in phase III trials.

[Benjamin Rich @BenRichMD]

Elective nodal RT (with 6 months of ADT) for oligorecurrent prostate cancer to the pelvis results in impressive 69% bRFS at 3 years beating MDT arm.

[Nat Lester-Coll, MD @DrLesterColl]

#ESTRO24 @piet_ost presenting outcomes of STORM randomized Ph II of MDT v ENRT for oligorecurrent prostate cancer #pcsm

✅ ENRT ⬆️BRFS, LRFS

MDT a/w 8-fold ⬆️ nodal recurrence 3➡️25%

Omitting PB ⬆️ local recurrences 3-fold (5➡️14%), but also increases GU2+ toxicity

[Evan Thomas MD/PhD @EvanThomas84]

https://t.co/240JGGkwa9

Congratulations to my friend and mentor! (Also to @UMiamiHealth for such a strong hire)

[Benjamin Rich @BenRichMD]

@ElliotServaisMD @SteligaMD @DrewMoghanaki @Daniela_Molena @yooeeemd Cyberknife and Gammaknife were terms introduced by neurosurgeons, not radiation oncologists. Our rad oncologist specialty marketing department is not that bold😂

[Dr. Nina Niu Sanford @NiuSanford]

Rad onc = #1 for professional fulfillment 🙌🏽

[PDBrown @PDBrownOnc]

What are the cognitive outcomes for glioma w/ modern focal RT?
· Prospective Study F/U up to 11 years!
· Stable w/some improvement
· Despite more aggressive tumors outcomes comparable to Watchful-Waiting cohort
https://t.co/KlrpfZUH8i